BAY-3827
目录号 : GC67772BAY-3827是一种强效且选择性的AMP活化蛋白激酶（AMPK）抑制剂，在低浓度ATP（10µM）下IC50值为1.4nM，在高浓度ATP（2mM）下为15nM。
Cas No.:2377576-35-5
Sample solution is provided at 25 µL, 10mM.
_1-3.$$$39978408@51.jpg');)
_1-9.$$$38538795@65.jpg');)
_1-9.$$$39112701@51.jpg');)
_1-7.$$$37316672@70.jpg');)
_366-372.$$$36198801@70.jpg');)
.$$$38565142@65.jpg');)
_1867-1883.$$$33248023@67.jpg');)
_eads6055.$$$39977546@45.jpg');)
_eadm9805.$$$40080571@45.jpg');)
_eadj3020.$$$39666821@45.jpg');)
_1-20.$$$39757301@28.jpg');)
_1-24.$$$38898113@28.jpg');)
_273-287.$$$36806353@46.jpg');)
_1-16.$$$37156877@44.jpg');)
_1-19.$$$37460805@44.jpg');)
_1291-1307.$$$34518654@46.jpg');)
BAY-3827 is a potent and selective AMP-activated protein kinase (AMPK) inhibitor with IC50 values of 1.4nM at low ATP concentration (10µM) and 15nM at high ATP concentration (2mM)[1]. AMPK is a global sensor of cellular energy levels and a key regulator of nutrient metabolism[2]. BAY-3827 inhibits the phosphorylation of acetyl-CoA carboxylase (ACC)[3].
In vitro, treatment of human prostate cancer cell lines (LNCaP, VCaP cells) with BAY-3827 (1nM) for 24h or 48h downregulated the expression of multiple genes involved in lipid metabolism, such as LIPE, PRKAR2B, AKT3, and CPT1 family members[4]. Pretreatment of cardiac fibroblasts (HCFs) with BAY-3827 (500nM) for 1h effectively eliminated the phosphorylation of intracellular acetyl-CoA carboxylase (ACC) induced by SGLT2i[5]. Treatment of corneal epithelial cells infected with Pseudomonas aeruginosa (PA) with BAY-3827 (10µM) significantly reduced the levels of inflammatory markers IL-6 and IL-8 in the cells[6].
In vivo, stereotactic injection of BAY-3827 (5µL, 100µM) into neurotrophic tyrosine kinase receptor 1 (NTRK1) knockdown mice exacerbated the impairment of working memory and reference memory, and exacerbated depressive-like behavior[7].
References:
[1] Lemos C, Schulze V K, Baumgart S J, et al. The potent AMPK inhibitor BAY-3827 shows strong efficacy in androgen-dependent prostate cancer models[J]. Cellular Oncology, 2021, 44(3): 581-594.
[2] He L, Zhou X, Huang N, et al. AMPK regulation of glucose, lipid and protein metabolism: mechanisms and nutritional significance[J]. Current Protein and Peptide Science, 2017, 18(6): 562-570.
[3] Strang J E, Astridge D D, Nguyen V T, et al. Small molecule modulators of AMP-activated protein kinase (AMPK) activity and their potential in cancer therapy[J]. Journal of Medicinal Chemistry, 2025, 68(3): 2238-2254.
[4] Lemos C, Schulze V K, Baumgart S J, et al. The Potent and Selective AMPK Inhibitor BAY-3827 Shows Strong Efficacy in Androgen-Dependent Prostate Cancer Models[J]. 2020.
[5] Baufays C, Cumps J, Dufeys C, et al. Comparison of the Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Cardiac Fibroblast Properties[J]. International Journal of Molecular Sciences, 2025, 26(20): 10098.
[6] Cao D W, Ramachandran R A, Robertson D M. AMPK modulates mitochondrial homeostasis during Pseudomonas aeruginosa infection in corneal epithelial cells[J]. Investigative Ophthalmology & Visual Science, 2024, 65(7): 1971-1971.
[7] Yang K, Wu J, Li S, et al. NTRK1 knockdown induces mouse cognitive impairment and hippocampal neuronal damage through mitophagy suppression via inactivating the AMPK/ULK1/FUNDC1 pathway[J]. Cell Death Discovery, 2023, 9(1): 404.
BAY-3827是一种强效且选择性的AMP活化蛋白激酶（AMPK）抑制剂，在低浓度ATP（10µM）下IC50值为1.4nM，在高浓度ATP（2mM）下为15nM[1]。AMPK是细胞能量水平的总传感器，也是营养物质代谢的关键调节器[2]。BAY-3827能够抑制乙酰辅酶A羧化酶（ACC）的磷酸化[3]。
在体外，BAY-3827（1nM）处理人类前列腺癌细胞系（LNCaP、VCaP细胞）24h或48h，下调了多个参与脂质代谢的基因的表达，例如LIPE、PRKAR2B、AKT3和CPT1家族成员[4]。BAY-3827（500nM）预处理心肌成纤维细胞（HCFs）1h，有效消除了SGLT2i诱导的细胞内乙酰辅酶A羧化酶（ACC）的磷酸化[5]。BAY-3827（10µM）处理感染铜绿假单胞菌（PA）的角膜上皮细胞，显著降低了细胞中炎症标志物IL-6和IL-8的水平[6]。
在体内，BAY-3827（5µL, 100µM）通过脑立体定向注射处理神经营养酪氨酸激酶受体1（NTRK1）敲低小鼠，加剧了小鼠的工作记忆和参考记忆损伤，加剧了抑郁样行为[7]。
| Cell experiment [1]: | |
Cell lines | LNCaP、VCaP cells |
Preparation Method | LNCaP and VCaP cells were treated with 1nM R1881, enzalutamide or BAY-3827, as indicated for 24 or 48h. RNA was extracted using the RNeasy Plus Mini kit. Synthesis of cDNA was performed with the SuperScript® III First Strand Synthesis SuperMix for qRT-PCR. Analysis was performed using the RT2 Proler™ PCR Array Human AMPK Signaling 330231. |
Reaction Conditions | 1nM; 24, 48h |
Applications | BAY-3827 regulates the expression of several genes involved in lipid metabolism such as LIPE, PRKAR2B, AKT3 and CPT1 family members. |
| Animal experiment [2]: | |
Animal models | C57BL/6J mice |
Preparation Method | 24 mice were divided randomly into the control group, the sh-NC group, the sh-NTRK1 group, and the sh-NTRK1+BAY-3827 group (n=6 in each group). The mice in the control group, the sh-NC group, and the shNTRK1 group were treated as described in the “Mouse transfection through brain stereotactic injection” section. BAY-3827, a selective inhibitor of AMPK, dispersed in PBS to prepare a concentration of 100µM. Next, the mice in the sh-NTRK1+BAY-3827 group were administered a brain stereotactic injection of BAY-3827 (5µL per mouse). After 1h, the mice were injected with the lentivirus carrying shRNA-NTRK1. All mice were then maintained for two weeks. |
Dosage form | 5µL, 100µM; brain stereotactic injection |
Applications | The treatment with BAY-3827 exacerbated the mouse depressive-like behavior induced by NTRK1 knockdown. |
References: | |
| Cas No. | 2377576-35-5 | SDF | Download SDF |
| 分子式 | C27H25FN6O | 分子量 | 468.53 |
| 溶解度 | DMSO : 25 mg/mL (53.36 mM; ultrasonic and warming and heat to 60°C) | 储存条件 | 4°C, protect from light |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 2.1343 mL | 10.6717 mL | 21.3434 mL |
| 5 mM | 426.9 μL | 2.1343 mL | 4.2687 mL |
| 10 mM | 213.4 μL | 1.0672 mL | 2.1343 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet